Enoxaparin Sodium
NDC Package 50090-3445-0
Package Information
Enoxaparin Sodium is injection is contraindicated in patients with:Active major bleeding History of immune-mediated heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies [see Warnings and Precautions (5.4)] Known hypersensitivity to enoxaparin sodium (e.g., pruritus, urticaria, anaphylactic/anaphylactoid reactions) [see Adverse Reactions (6.2)] Known hypersensitivity to heparin or pork products. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-3445 and is authorized under FDA application ANDA076726.
Identification & Billing
- RxCUI: 854235 - enoxaparin sodium 40 MG in 0.4 ML Prefilled Syringe
- RxCUI: 854235 - 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe
- RxCUI: 854235 - 0.4 ML ENX sodium 100 MG/ML Prefilled Syringe
- RxCUI: 854235 - enoxaparin sodium 40 MG per 0.4 ML Prefilled Syringe
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50090 - A-s Medication Solutions
- 50090-3445 - Enoxaparin Sodium
- 50090-3445-0 - 10 SYRINGE in 1 CARTON / .4 mL in 1 SYRINGE
- 50090-3445 - Enoxaparin Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50090-3445-0 identifies a specific commercial package of 10 syringe in 1 carton / .4 ml in 1 syringe of Enoxaparin Sodium, labeled by A-s Medication Solutions. This product is billed per "ML" milliliter and contains an estimated amount of 4 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on November 17, 2014. The current certification is valid through December 31, 2022.
How is this A-s Medication Solutions product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090344500. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 4 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.